Home | Business Weekly
WEBAcademia. Sharewatch. Manufacturing. Cambridge team claims MedTech world first. 17 Sep 2024 - 05:00. Silicon Valley ace is new Chief Executive of Cambridge Enterprise. 16 Sep 2024 - 05:00. ‘Brain gain’ boom as Cambridge industry-academia interface generates $1.35 billion. 04 Sep 2024 - 05:00.
News - Business Weekly
WEBR & D ‘brains’ to stay in Cambridge as Darktrace changes CEO. Thoma Bravo, the new US owner of Cambridge cyber security company Darktrace, has pledged that the brains of the business – the R & D team of some 300 people – will stay in the city despite CEO Poppy Gustafsson being replaced by Texas-based Jill Popelka. Tony Quested.
Neobe Therapeutics raises $2.34m to advance fight against cancer
WEBMar 4, 2024 · Cambridge-gated Neobe Therapeutics, a synthetic biology startup at the forefront of immuno-oncology innovation, has raised $2.34 million to advance its tumour microenvironment remodelling solution. Neobe CEO Pedro Correa de Sampaio. Credit – Neobe Therapeutics. The company is transforming cancer treatment through engineered live biotherapeutics.
Shareholders’ windfall as Johnson Matthey agrees to ... - Business …
WEBMar 19, 2024 · Johnson Matthey Plc, which has a major base at Cambridge Science Park, is returning £250 million to shareholders after agreeing to sell its Medical Device Components business (MDC) to Montagu Private Equity (Montagu) for …
Mission raises £25.2m to progress clinical development of key drugs
WEBMar 13, 2024 · Blue chip international investors have weighed into a £25.2 million fundraising round to back significant progress for Cambridge clinical stage biotech Mission Therapeutics. The company is developing first-in-class therapeutics that enhance mitophagy to promote cell/organ health.
Cambridge startup OutSee Ltd aims to unearth new drug targets …
WEBMar 12, 2024 · No-one could accuse Cambridge scientist Dr Julian Gough of pursuing a ‘get rich quick’ philosophy as he continues to cross the bridge between academia and business. Witness his latest venture, OutSee Ltd, which was founded to exploit large-scale genomics datasets by using its proprietary AI genomics technology …
Cambridge tech ecosystem valued at $191 billion by Dealroom
WEBMay 22, 2024 · The Cambridge tech ecosystem has a value of $191 billion, representing 18 per cent of the entire UK’s tech ecosystem and more than Spain and Italy combined, according to new analysis by Dealroom for Founders at the University of Cambridge. However, a statement in the analysis that Wayve – …
UK, US and European investment as Acteon is acquired
WEBUK, US and European investment as Acteon is acquired. 26 Mar, 2024. Newsdesk. Norwich-anchored Acteon Group, a global offshore energy infrastructure services business, has been acquired by private equity investors Buckthorn Partners and One Equity Partners (OEP). No figures have been disclosed for the international deal. Courtesy – Acteon Group.
New AstraZeneca blockbuster drugs will drive record growth in …
WEBMay 20, 2024 · It’s a move that makes a fistful of dollars look like small change. Cambridge Big Biotech AstraZeneca has launched the most ambitious growth blueprint in the history of this and possibly any other life science company in a glory push that could reel in many more billions than the R & D outlay in the form of several new blockbuster drugs.
Begbies Traynor fortifies war chest to underpin growth blueprint
WEBFeb 25, 2024 · Begbies Traynor fortifies war chest to underpin growth blueprint. Professional services consultancy Begbies Traynor Group plc has agreed a new multimillion pound debt facility with HSBC which provides further headroom for growth. The company, which has 10 offices in the East of England, expects to continue profiting from a mix of organic growth ...